O-7 FOLFIRI ± napabucasin in patients with previously treated metastatic colorectal cancer: Overall survival results from the phase 3 CanStem303C study

Authors :: Matthew Hitron
Christina Wu
V. Chiu
Sang Cheul Oh
Andrés Cervantes
Julien Taieb
R. Xu
Bo Xu
Johanna C. Bendell
Axel Grothey
E. Van Cutsem
Marwan Fakih
Niall C. Tebbutt
Takayuki Yoshino
J. Tabernero
Manish A. Shah
Alfredo Falcone
Marilyn Fontaine
Kensei Yamaguchi
Jiri Tomasek
Source :: Annals of Oncology. 32:S220
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Colorectal cancer
business.industry
Hematology
medicine.disease
Internal medicine
Overall survival
medicine
FOLFIRI
In patient
Previously treated
business
Napabucasin

Full Text Access

Tools